Biomed

News Biomed

• NanoString Technologies Completes $15.3 Million Series E Financing

  NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, announced the completion of a $15.3 million Series E Preferred Stock issuance. New investors in the transaction included Morgan Stanley Expansion more

• Aquapharm appoints Dr Simon Best OBE FRSE as new CEO

  Aquapharm Biodiscovery announced the close of a £4.2 million investment from existing investors Aescap Venture, Tate & Lyle Ventures, Highlands and Islands Enterprise and NESTA. Alongside the completion of the financing, Aquapharm has appointed the biotech entrepreneur Simon Best as CEO. Current CEO more

• Learning how the pieces responsible for interpreting the human genome work

  The human genome complete sequencing project in 2003 revealed the enormous instruction manual necessary to define a human being. However, there are still many unanswered questions. There are few indications on where the functional elements are found in this manual. To explain how we develop, scienti more

White papers Biomed

• Optimization of Transfection Efficiency in Chick Embryo Hepatocytes and HepG2 Cells
  

  Cell and molecular biology studies have been facilitated by transfection, a technology that can deliver material like DNA, RNA, and protein into cells. However, there are multiple reagents on the market, and a careful study must be perform­ed in order to find a suitable technique for your particular cellular system. One of the most effective re-agents that was available on the market in the early 90's was DOTMA (N-[1-(2,3-dioleyloxy)propyl]-N,N,N-tri-methylammonium chloride). more

• LightCycler® 480 and 1536 Real-Time PCR Systems - Powerful Solutions for Different Throughput Levels
  

  During the past few years real-time PCR has been proven to be a key technology for gene expression analysis, for instance for gene expression profiling and array verification studies and for the genotyping of single nucleotide polymorphisms, both in industrial and public research, with major impact on the fields of drug discovery, molecular medicine and personalized health care more

Publications Biomed

• Coagulation‐induced resistance to fluid flow in small‐diameter vascular grafts and graft mimics measured by purging pressure

  Abstract In this study, the coagulation‐induced resistance to flow in small‐diameter nonpermeable Tygon tubes and permeable expanded polytetrafluoroethylene (ePTFE) vascular grafts was characterized by measuring the upstream pressure needed to purge the coagulum from the tube lumen. This purging more

• Application of nanosheets as an anti‐adhesion barrier in partial hepatectomy

  Abstract Postoperative adhesion often causes serious adverse effects such as bowl obstruction, chronic abdominal pain, pelvic pain, and infertility. We previously reported that a poly‐L‐lactic acid (PLLA) nanosheet can efficiently seal a surgical incision without scarring. In this report, we exa more

• Multilayer scaffold of electrospun PLA–PCL–collagen nanofibers as a dural substitute

  Abstract Dural closure after the neurosurgery can prevent postoperative complications. Although many types of dural substitute have been developed, most of them lack functional and structural characteristics compared with the natural dura mater. In this study, we used electrospinning method to f more

Market studies Biomed

• Satoris, Inc. - Product Pipeline Analysis

  Satoris, Inc. - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Satoris, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, tr more

• AutoGenomics, Inc. - Product Pipeline Analysis

  AutoGenomics, Inc. - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the AutoGenomics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development more

• Bharat Immunologicals and Biologicals Corporation Limited (524663) - Financial and Strategic SWOT Analysis Review

  Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a pharmaceutical company. It is engaged in the development and supply of oral polio vaccines in India for the treatment of Poliomyelitis or infantile paralysis in children. BIBCOL also has ambitious plans to take up the productio more

Websites Biomed